REZIPRES
- Product NDC
- 71863-210
- 11-digit product format
- 718630210
- Labeler code
- 71863
- Product ID
- 71863-210_ca19f252-3856-4167-87fe-ef6d928dbe20
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ephedrine hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Eton Pharmaceuticals, Inc.
- Application
- NDA213536
- Marketing category
- NDA
- Marketing start
- 2021-06-14
- Marketing end
- 0000-00-00
- Substance
- EPHEDRINE HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71863-210-06 | 71863021006 | 10 AMPULE in 1 CARTON (71863-210-06) > 5 mL in 1 AMPULE (71863-210-05) | 10 ampule | 2021-10-01 | 0000-00-00 | No | No | Current |